Enhanced potency of the polymeric fluoropyrimidine CF10 to KRAS-mutant colorectal cancer cells

被引:0
|
作者
Gmeiner, William H. [1 ]
Manandhar, Mandira [1 ]
Hinds, Amanda M. [1 ]
Holmes, Julija [1 ]
Vidi, Pierre [1 ]
Tsunoda, Toshiyuki [2 ]
Shirasawa, Senji [2 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Fukuoka Univ, Fac Med, Fukuoka, Fukuoka, Japan
关键词
D O I
10.1158/1538-7445.AM2019-2079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2079
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization
    Maruyama, Kohei
    Shimizu, Yuki
    Nomura, Yumi
    Oh-hara, Tomoko
    Takahashi, Yuki
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [22] Metabolomic Approach to Identify Potential Biomarkers in KRAS-Mutant Pancreatic Cancer Cells
    Kim, Boyun
    Jung, Jewon
    BIOMEDICINES, 2024, 12 (04)
  • [23] Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways
    Liu, Yan-fei
    Feng, Zhi-qiang
    Chu, Tian-hao
    Yi, Ben
    Liu, Jun
    Yu, Haiyang
    Xue, Jun
    Wang, Yi-jia
    Zhang, Chun-ze
    PHYTOMEDICINE, 2024, 126
  • [24] Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
    Zhou, Xinyi
    Xiao, Qian
    Fu, Dongliang
    Zhang, Haochen
    Tang, Yang
    He, Jinjie
    Hu, Yeting
    Kong, Xiangxing
    Teng, Fei
    Liu, Xiangrui
    Yuan, Ying
    Ding, Kefeng
    CANCER BIOLOGY & MEDICINE, 2022, 19 (02) : 213 - +
  • [25] Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
    Liu, Jungang
    Huang, Xiaoliang
    Liu, Haizhou
    Wei, Chunyin
    Ru, Haiming
    Qin, Haiquan
    Lai, Hao
    Meng, Yongsheng
    Wu, Guo
    Xie, Weishun
    Mo, Xianwei
    Johnson, Caroline H.
    Zhang, Yawei
    Tang, Weizhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [26] Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
    Steve Wagner
    Georgios Vlachogiannis
    Alexis De Haven Brandon
    Melanie Valenti
    Gary Box
    Liam Jenkins
    Caterina Mancusi
    Annette Self
    Floriana Manodoro
    Ioannis Assiotis
    Penny Robinson
    Ritika Chauhan
    Alistair G. Rust
    Nik Matthews
    Kate Eason
    Khurum Khan
    Naureen Starling
    David Cunningham
    Anguraj Sadanandam
    Clare M. Isacke
    Vladimir Kirkin
    Nicola Valeri
    Steven R. Whittaker
    Oncogene, 2019, 38 : 1717 - 1733
  • [27] Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
    Xinyi Zhou
    Qian Xiao
    Dongliang Fu
    Haochen Zhang
    Yang Tang
    Jinjie He
    Yeting Hu
    Xiangxing Kong
    Fei Teng
    Xiangrui Liu
    Ying Yuan
    Kefeng Ding
    Cancer Biology & Medicine, 2022, (02) : 213 - 228
  • [28] Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
    Jungang Liu
    Xiaoliang Huang
    Haizhou Liu
    Chunyin Wei
    Haiming Ru
    Haiquan Qin
    Hao Lai
    Yongsheng Meng
    Guo Wu
    Weishun Xie
    Xianwei Mo
    Caroline H. Johnson
    Yawei Zhang
    Weizhong Tang
    Journal of Translational Medicine, 19
  • [29] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Qiming Zhou
    Yao Peng
    Fenfen Ji
    Huarong Chen
    Wei Kang
    Lam-Shing Chan
    Hongyan Gou
    Yufeng Lin
    Pingmei Huang
    Danyu Chen
    Qinyao Wei
    Hao Su
    Cong Liang
    Xiang Zhang
    Jun Yu
    Chi Chun Wong
    Nature Communications, 14
  • [30] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Zhou, Qiming
    Peng, Yao
    Ji, Fenfen
    Chen, Huarong
    Kang, Wei
    Chan, Lam-Shing
    Gou, Hongyan
    Lin, Yufeng
    Huang, Pingmei
    Chen, Danyu
    Wei, Qinyao
    Su, Hao
    Liang, Cong
    Zhang, Xiang
    Yu, Jun
    Wong, Chi Chun
    NATURE COMMUNICATIONS, 2023, 14 (01)